Comparison of meeting abstracts and subsequent articles

Comment

Chi-Tai Fang et al. JAMA. 2006.

. 2006 Aug 9;296(6):653.

doi: 10.1001/jama.296.6.653-a.

No abstract available

Comment on

Transition from meeting abstract to full-length journal article for randomized controlled trials.
Toma M, McAlister FA, Bialy L, Adams D, Vandermeer B, Armstrong PW. Toma M, et al. JAMA. 2006 Mar 15;295(11):1281-7. doi: 10.1001/jama.295.11.1281. JAMA. 2006. PMID: 16537738

Transition from meeting abstract to full-length journal article for randomized controlled trials.
Toma M, McAlister FA, Bialy L, Adams D, Vandermeer B, Armstrong PW. Toma M, et al. JAMA. 2006 Mar 15;295(11):1281-7. doi: 10.1001/jama.295.11.1281. JAMA. 2006. PMID: 16537738
Presentation of nonfinal results of randomized controlled trials at major oncology meetings.
Booth CM, Le Maître A, Ding K, Farn K, Fralick M, Phillips C, Cescon DW, Meyer RM. Booth CM, et al. J Clin Oncol. 2009 Aug 20;27(24):3938-44. doi: 10.1200/JCO.2008.18.8771. Epub 2009 Jul 20. J Clin Oncol. 2009. PMID: 19620490
Presentations of phase 2 clinical trial abstracts at a national oncology meeting: potential implications for subsequent publication in the peer-reviewed literature.
Markman M. Markman M. Oncology. 2006;71(1-2):146-7. doi: 10.1159/000100524. Epub 2007 Mar 9. Oncology. 2006. PMID: 17347590 No abstract available.
Conversion rates of abstracts presented at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting into full-text journal articles.
Yoon PD, Chalasani V, Woo HH. Yoon PD, et al. BJU Int. 2012 Aug;110(4):485-9. doi: 10.1111/j.1464-410X.2011.10879.x. Epub 2012 Feb 2. BJU Int. 2012. PMID: 22300438 Review.
A "how-to" guide in preparing abstracts and poster presentations.
Boullata JI, Mancuso CE. Boullata JI, et al. Nutr Clin Pract. 2007 Dec;22(6):641-6. doi: 10.1177/0115426507022006641. Nutr Clin Pract. 2007. PMID: 18042952 Review.